https://www.thepeptidenewsroom.com/review-says-glp-1-drugs-may-calm-allergic-inflammation-but-human-trials-are-miss/ The Peptide Newsroom en 2026-09-29 Review Says GLP-1 Drugs May Calm Allergic Inflammation, But Human Trials Are Missing https://www.thepeptidenewsroom.com/lower-glp-1-levels-linked-to-endometrial-cancer-in-obese-women-but-validation-is/ The Peptide Newsroom en 2026-09-29 Lower GLP-1 Levels Linked to Endometrial Cancer in Obese Women, But Validation Is Missing https://www.thepeptidenewsroom.com/epitalon-study-reports-telomere-lengthening-in-human-cells-but-the-work-stops-at/ The Peptide Newsroom en 2026-09-29 Epitalon Study Reports Telomere Lengthening in Human Cells, But the Work Stops at the Dish https://www.thepeptidenewsroom.com/novo-nordisk-rebrands-glp-1s-as-lifestyle-drugs-and-patients-become-customers/ The Peptide Newsroom en 2026-09-28 Novo Nordisk Rebrands GLP-1s as Lifestyle Drugs, And Patients Become Customers https://www.thepeptidenewsroom.com/doctor-sees-promise-in-peptides-but-calls-high-dose-glp-1-use-an-atomic-bomb/ The Peptide Newsroom en 2026-09-28 Doctor Sees Promise in Peptides, But Calls High-Dose GLP-1 Use an 'Atomic Bomb'